Health Care & Life Sciences » Biotechnology | Capricor Therapeutics Inc.

Capricor Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,457.90
11,011.80
13,567.30
17,542.10
14,866.90
7,542.20
Total Accounts Receivable
0.20
360.20
211.90
223.30
344.60
204.90
Other Current Assets
222.80
235.50
210.60
342.90
501.20
724.20
Total Current Assets
3,680.80
11,607.50
13,989.90
18,108.30
15,712.70
8,471.30
Net Property, Plant & Equipment
74.20
229.50
318.60
435.30
372.10
574.20
Intangible Assets
1,727.20
1,739.80
1,691.00
142.30
93.00
49.80
Other Assets
55.70
55.30
70.20
61.40
96.00
151.80
Total Assets
5,537.90
13,632.10
16,069.60
18,747.40
16,273.80
9,247.10
Accounts Payable
1,506.50
1,699.30
2,530.50
3,038.80
1,496.30
Other Current Liabilities
546.40
4,600.40
3,998.20
1,856.40
174.40
Total Current Liabilities
2,052.90
6,299.60
6,528.70
4,895.20
1,670.70
Long-Term Debt
3,961.70
9,155.90
9,155.90
17,005.90
3,376.30
Other Liabilities
58.10
4,425.30
1,416.80
849.50
-
Total Liabilities
6,072.80
19,880.80
17,101.30
22,750.50
5,046.90
Common Equity (Total)
534.90
6,248.70
1,031.80
4,003.20
11,226.90
Total Shareholders' Equity
534.90
6,248.70
1,031.80
4,003.20
11,226.90
Total Equity
534.90
6,248.70
1,031.80
4,003.20
11,226.90
Liabilities & Shareholders' Equity
5,537.90
13,632.10
16,069.60
18,747.40
16,273.80

About Capricor Therapeutics

View Profile
Address
8840 Wilshire Boulevard
Beverly Hills California 90211
United States
Employees -
Website http://www.capricor.com
Updated 07/08/2019
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA.